Dr He on the Evaluation of Camrelizumab Plus Rivoceranib in Unresectable HCC
Aiwu Ruth He, MD, PhD, discusses the evaluation of camrelizumab plus rivoceranib in unresectable hepatocellular carcinoma.
Source: onclive.com
Cares 310 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cares 310. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cares 310 Today - Breaking & Trending Today
Importance of Assessing Liver Function in HCC
Drs Vogel and Singal discuss the critical importance of assessing liver function in hepatocellular carcinoma patients, as it impacts prognosis and treatment strategies; they mention the evolution from Child-Pugh scoring to the ALBI score, which uses albumin and bilirubin levels, for a more objective evaluation of liver health.
Source: onclive.com